Ferenc Tracik
Chief Tech/Sci/R&D Officer chez NEUROSENSE THERAPEUTICS LTD.
Fortune : 223 771 $ au 31/03/2024
Profil
Ferenc Tracik is currently the Chief Medical Officer at Neurosense Therapeutics Ltd.
Prior to this, he worked as the Managing Director-Germany Specialty Medicines at Teva Pharmaceutical Industries Ltd.
from 2013 to 2017, and as the VP-Medical Europe & Canada at Biogen, Inc. from 2017 to 2020.
He also served as the Global Head-Medical at Orphazyme A.
Tracik holds a doctorate degree from Freie Universität Berlin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/04/2024 | 122 951 ( 0,90% ) | 223 771 $ | 31/03/2024 |
Postes actifs de Ferenc Tracik
| Sociétés | Poste | Début |
|---|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Chief Tech/Sci/R&D Officer | 01/12/2021 |
Anciens postes connus de Ferenc Tracik
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/11/2020 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/04/2017 |
| ORPHAZYME A/S | Corporate Officer/Principal | - |
Formation de Ferenc Tracik
| Freie Universität Berlin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| BIOGEN INC. | Health Technology |
| ORPHAZYME A/S | Health Technology |
| NEUROSENSE THERAPEUTICS LTD. | Health Technology |
